Aerpio Pharmaceuticals, Inc. Business Finance Contracts & Agreements
28 Contracts & Agreements
- Note Agreements (4 contracts)
- Purchase Agreements (5)
- Registration Rights Agreements (5)
- Stock Agreements (7)
- Subscription Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (3)
- Form of Registration Rights Agreement, by and among Aadi Bioscience, Inc. and the purchasers thereto (Filed With SEC on December 20, 2024)
- Subscription Agreement, dated December 19, 2024, and each purchaser identified on Exhibit A thereto (Filed With SEC on December 20, 2024)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on December 20, 2024)
- Stock Purchase Agreement, dated December 19, 2024, among Aadi Bioscience, Inc., KAKEN INVESTMENTS INC., KAKEN PHARMACEUTICAL CO., LTD., and Aadi Subsidiary, Inc (Filed With SEC on December 20, 2024)
- Amendment No.3 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, effective as of July 31, 2024, by and between Aadi Bioscience, Inc. and... (Filed With SEC on November 6, 2024)
- Amendment No.2 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated April 1, 2024, by and between Aadi Bioscience, Inc. and Fresenius... (Filed With SEC on May 8, 2024)
- Description of Registrant's Capital Stock (Filed With SEC on March 13, 2024)
- Form of Registration Rights Agreement, dated September 22, 2022, by and among the Company and the Purchasers (Filed With SEC on September 22, 2022)
- Form of Securities Purchase Agreement, dated September 22, 2022, by and among the Company and the Purchasers (Filed With SEC on September 22, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on September 22, 2022)
- Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated as of January 13, 2022, by and between the Company and Fresenius Kabi, LLC (Filed With SEC on May 12, 2022)
- Description of common stock (Filed With SEC on March 17, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 27, 2021)
- Registration Rights Agreement, dated August 26, 2021, by and between Aadi Bioscience, Inc. (formerly known as Aerpio Pharmaceuticals, Inc.) and certain purchasers listed therein (Filed With SEC on August 27, 2021)
- Contingent Value Rights Agreement dated August 26, 2021, by and between Aerpio Pharmaceuticals, Inc., Cheryl Cohen, as Holder Representative, and American Stock Transfer & Trust... (Filed With SEC on August 27, 2021)
- Asset Purchase Agreement dated August 17, 2021, by and between Aerpio Pharmaceuticals, Inc. and EyePoint Pharmaceuticals, Inc (Filed With SEC on August 23, 2021)
- Subscription Agreement, dated May 16, 2021, by and among Aerpio Pharmaceuticals, Inc. and each purchaser identified on Exhibit A thereto (Filed With SEC on May 17, 2021)
- Underwriting Agreement, dated June 26, 2018, between the Company and Guggenheim Securities, LLC, as representative of the several underwriters party thereto (Filed With SEC on June 27, 2018)
- Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on December 18, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 17, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on March 17, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 17, 2017)
- AERPIO PHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 17, 2017)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK OF AERPIOPHARMACEUTICALS, INC. (Filed With SEC on March 17, 2017)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- PROMISSORY NOTE (Filed With SEC on August 14, 2013)
